VentiRx Overview
VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
VentiRx has assembled a team of experienced biotechnology professionals with decades of business development and drug development experience in various therapeutic areas.
VentiRx was founded in June 2006 by...More»
VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
VentiRx has assembled a team of experienced biotechnology professionals with decades of business development and drug development experience in various therapeutic areas.
VentiRx was founded in June 2006 by Michael Kamdar and Robert Hershberg, M.D., Ph.D. along with Frazier Healthcare and ARCH Venture Partners. VentiRx is a privately held organization headquartered in San Diego, CA with operations in Seattle, WA.«Less
Key People
Management
- Michael Kamdar, Chief Business Officer
- Robert Hershberg, Chief Medical Officer
- Gregory Dietsch, VP Research
- Jeffry Howbert, Head of Chemistry
- Tressa Randall, Senior Director of Regulatory Affairs
- Kristi Manjarrez, Senior Director of Clinical Affairs
- MariJo Gleeson, Director of Finance
- Andre Basbaum, Director of Business Development
- Maura-Ann Matthews, Director of Product Development
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 03/2007 | Series A | 26.6M | Unknown |
Products
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
VentiRx Gets $25M In Series A Extension
Jan 12, 2010 - 0 comments
Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines
Jan 7, 2009 - 0 comments
VentiRx on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...

Profile
Opinions
